Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
30 July 2019 | Story Valentino Ndaba | Photo Barend Nagel
HR Kovsie Care
The great poet Virgil once said: “The greatest wealth is health.”

The World Health Organisation (WHO) recently listed burnout as an occupational phenomenon in the 11th Revision of the International Classification of Diseases. Although not classified as a medical condition, its imprint on employees’ health status is absolute. 

The hallmark of any conducive workplace is its ability to assist employees to successfully manage stress. The Occupational Development and Employee Wellness Division at the University of the Free State’s (UFS) Department of Human Resources (HR) continues to make concerted efforts to ensure the good mental and physical health of all staff members.

Solving an occupational dilemma

Burnout is characterised by feelings of energy depletion, increased mental distance from one’s job, and reduced professional efficacy. Over the past few years HR has launched various preventive programmes for support and academic staff as well as service workers.

One of these initiatives is the Power Hour sessions which are hosted at lunchtime across all campuses. These interactive platforms cover topics ranging from pain, emotional intelligence, bullying, healthy eating habits, resilience and anxiety. 

Fitness as a stress reliever

Over the years what were known as Takkie Tuesdays and Thursdays have evolved into “Take a Break & Feel the difference”. Staff members take 30-minute walks during lunchtime to boost productivity, confidence, energy levels, concentration and creativity while reducing stress symptoms and preventing lifestyle illnesses.

“Our mission is to cultivate a culture of health and wellness. We believe that when the culture is conducive it affects staff performance. The main purpose is to create an environment where people are mentally and physically well,” said Burneline Kaars, head of the wellness division.

Caring is sharing knowledge

True to its tagline “Care”, which stands for: Create, Attract, Retain, Excellence, the division works around the clock to care for staff members’ mental wellbeing. This includes referring those who need curative measures for free counselling provided by Careways.

Another way through which the division inspires employees to enrich their minds, bodies and souls is the Workout@Work programme that offers cardio exercises after office hours and the Pedometer Challenge which tracks physical movement throughout the day.

“It all boils down to being more active. It gets people to leave the office, enjoy the sun, and become more creative and energised,” says Arina Engelbrecht, Employee Wellness Specialist. 



News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept